Skip to main content
Log in

Influence of tumor derived fibroblasts and 1,25-dihydroxyvitamin D3 on growth of breast cancer cell lines

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Fibroblasts are known to be present in variable amounts in human breast adenocarcinoma tissue. In order to investigate if they influence in some way the proliferation rate of the carcinoma cells, we developed a coculture model in which cells of well characterized breast epithelial cell lines were seeded and grown in microchamber slides along with fibroblasts derived from breast tumor biopsies. As representatives of hormone dependent and independent tumor cells, we used MCF-7 and BT-20 cell lines. A third line, NPM-21T, derived from non proliferating mastopathy cells immortalized by SV-40 T DNA transfection, was representative of non tumor epithelial cells. The proliferation rate of the adenocarcinoma and epithelial cells was assessed by measurement of the BrdU labeling index, the cells being identified by specific β-actin immunostaining. It was found that the proliferation of the adenocarcinoma cells was significantly increased in the presence of fibroblasts, while that of immortalized cells was not. Moreover, 1,25(OH)2D3, which was known to be a negative regulator of carcinoma cell growth, was found to be able also to blunt the overgrowth in the presence of fibroblasts. The absence of response of NPM-21T cells to the presence of fibroblasts suggests that the tumor cells could be the origin of their own overgrowth, through an indirect mechanism mediated by the fibroblasts. The factors which are involved and the 1,25(OH)2D3 mechanism of action are not yet identified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

1,25(OH)2D3 :

1,25-dihydroxycholecalciferol

BrdU:

5-bromo-2'-deoxyuridine

LI:

labeling index

ER, PGR, VDR:

estrogen, progesterone, and 1,25(OH)2D3 receptors

EGF, EGF-R:

epidermal growth factor and epidermal growth factor receptor

References

  1. Houdebine ML: Role des hormones dans l'embryogénèse et le développement du sein.In: Scali P, Villet R (eds) Hormones et Sein. Masson, Paris, 1991, pp 12–25

    Google Scholar 

  2. Imagawa W, Bandyopadhay GK, Nandi S: Regulation of mammary epithelial cell growth in mice and rats. Endocr Revs 11:494–523, 1990

    Google Scholar 

  3. Osborne MP: Breast development and anatomy.In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds) Breast Diseases. J.B. Lippincott, 1991, pp 1–13

  4. Wasner G, Hennermann I, Kratochwil K: Ontogeny of mesenchymal androgen receptors in the embryonic mouse mammary gland. Endocrinol 113:1771–1780, 1983

    Google Scholar 

  5. Levine JF, Stockdale FE: 3T3-L1 adipocytes promote the growth of mammary gland. Exp Cell Res 151:112–122, 1984

    Google Scholar 

  6. Frampton RJ, Omond A, Eisman JA: 1,25-dihydroxyvitamin D3 metabolites inhibit human cancer cell growth. Cancer Res 43:443–447, 1983

    Google Scholar 

  7. Chouvet C, Vicard E, Devonec M, Saez S: 1,25-dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). Steroid Biochem 24:373–376, 1986

    Google Scholar 

  8. Reichel H, Koeffler HP, Norman AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980–991, 1989

    Google Scholar 

  9. Horwitz KB, Zava DT, Thilagar A, Jensen EL, McGuire WL: Steroid receptor analysis of nine human breast cancer cell lines. Cancer Res 38:2434–2437, 1978

    Google Scholar 

  10. Lebeau J, Goubin G: Amplification of the epidermal growth factor receptor gene in the BT-20 breast carcinoma cell line. Int J Cancer 40:189–191, 1987

    Google Scholar 

  11. Gamby Ch, Hamelin R, Raux H, Salle V, Crepin M: Human epithelial cell lines from normal mammary tissue and from benign mastopathies. Cancer Detect Prev 16:S 71–74, 1992

    Google Scholar 

  12. Lasfargues EY: Human mammary tumors.In: Kruse PF, Patterson MK (eds) Tissue Culture: Methods and Applications. Academic Press, New York, 1973, pp 45–50

    Google Scholar 

  13. Israel N, Saez S: Relation between steroid receptor content and the response to hormone addition in isolated human breast cancer cells in short-term culture. Cancer Res 38:4314–4317, 1978

    Google Scholar 

  14. Morstyn G, Hsu SM, Kinsella T, Gratzner H, Russo A, Mitchell JB: Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest 72:1844–1850, 1983

    Google Scholar 

  15. Saez S, Falette N, Guillot C, Meggouh F, Lefebvre MF, Crepin M: 1,25(OH) vitamin D3 modulation of mammary tumor cell growth in vitro and in vivo. Breast Cancer Res Treatment 27:69–82, 1993

    Google Scholar 

  16. Van Roozendaal CEP, Van Ooijen B, Klijn JGM, Claassen C, Eggermont AMM, Henzen-Logmans C, Foekens JA: Stromal influences on breast cancer cell growth. Br J Cancer 65:77–81, 1992

    Google Scholar 

  17. Okumura Y, Hamada JZ, Cavanaugh PG, Nicolson GL: Preferential growth stimulation of metastatic rat mammary adenocarcinoma cells by organ-derived syngeneic fibroblasts in vitro. Invasion Metastasis 12: 275–283, 1992

    Google Scholar 

  18. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N: Analysis of IGF-I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509–517, 1989

    Google Scholar 

  19. McGrath CM: Augmentation of response of normal mammary epithelial cells to estradiol by mammary stroma. Cancer Res 43:1355–1360, 1983

    Google Scholar 

  20. Haslam SZ, Levely ML: Estrogen responsiveness of normal mouse mammary cells in primary culture: association of mammary fibroblasts with estrogenic regulation of progesterone receptors. Endocrinol 116:1835–1844, 1985

    Google Scholar 

  21. Peres R, Betsholtz C, Westermark B, Heldin CH: Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 47:3425–3429, 1987

    Google Scholar 

  22. Cullen KJ, Smith HS, Hill LS, Rosen N, Lippman ME: Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978–4985, 1991

    Google Scholar 

  23. Thompson EW, Lippman ME, Dickson RB: Regulation of basement membrane invasiveness in human breast cancer. Mol Cell Endocrinol 82:C203-C208, 1991

    Google Scholar 

  24. Eisman JA, Sutherland RL, McMenemy L, Fragonas JC, Musgrove EA, Pang GYN: Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T47D human breast cancer cells. J Cell Physiol 138:611–616, 1989

    Google Scholar 

  25. Demirpence E, Balaguer P, Trousse F, Nicolas JC, Pons M, Gagne D: Antiestrogenic effects of alltrans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54:1458–1464, 1994.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lefebvre, M.F., Guillot, C., Crepin, M. et al. Influence of tumor derived fibroblasts and 1,25-dihydroxyvitamin D3 on growth of breast cancer cell lines. Breast Cancer Res Tr 33, 189–197 (1995). https://doi.org/10.1007/BF00665943

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00665943

Key words

Navigation